开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=812012, encodeId=f4f6812012b1, content=WB实验只重复了3次，然后做了转录组学，一共3组，每组n＝3，其他的实验倒是都n＞5，请问这种n<5的情况还能解释抢救一下吗😌😌，要是解释又该咋解释呢？跪求过来人指点迷津！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa7c2578479, createdName=1259c4d1m39暂无昵称, createdTime=Sat Aug 22 11:39:16 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890345, encodeId=1760890345d5, content=投稿历程： 9-26日：投稿 27日：退回修改 27日：再投 27日：Awaiting Admin Processing 29日：Awaiting SE Assignment 10-1日：Under Review 10-6日（周二）：Under Review 太快Under Review有可能是编辑内审，周一没有拒掉，看来是送外审了！希望能有个好消息。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82d75423544, createdName=胡墨乙, createdTime=Tue Oct 06 09:53:37 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225505, encodeId=fea81225505f2, content=投稿3天就显示：ADM: Office, Editorial Under Review，到现在已经10天还是这个状态，请问是送外审了还是还在编辑手里评估？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Thu Jun 09 20:43:19 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099754, encodeId=ac872099e5448, content=一审快5个月了，还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Thu Nov 10 22:45:24 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153667, encodeId=8f59215366ec8, content=很快显示Under review是还没送审么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=649b5469159, createdName=ms6000000380819267, createdTime=Sun Aug 20 00:27:15 CST 2023, time=2023-08-20, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2178598, encodeId=eff821e8598a9, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药学 经验分享：最新的中科院分区显示为2区非top，一个老牌药学期刊现在日落西山，真是令人大跌眼镜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1a4b2101714, createdName=有时候有石猴, createdTime=Mon Jan 01 15:26:49 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130419, encodeId=354f2130419da, content=状态是Office, Editorial，under review是编辑在看，还没送审吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da598638523, createdName=ms7000000124702508, createdTime=Sat May 06 11:02:30 CST 2023, time=2023-05-06, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=567095, encodeId=4a8c56e09554, content=投稿命中率:25.0 经验分享：2019年1月23 日投稿，十天之后要求提供由于投稿figure 中的 western-blot 原始图，当日提交原始图，原始图不用做任何说明，我们是将fugure图放上然后原始图放旁边，有时候一张膜上跑其他实验也没关系，只要是原始图就成，一周之后拒稿，理由是实验需要重复五次以上，我们只做三次~ 拒稿还是很快的~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbxIPfCRw9M3DTmzkUQmibZbat4YUHNQoajZUkJX9iaYPyTKicX9S8yeqW1hG0oiaj8rF3j0WalWoicmA/132, createdBy=1e302549420, createdName=young926, createdTime=Fri Feb 22 01:11:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232551, encodeId=02ea123255182, content=请问投稿时作者和机构那一步是添加什么邮箱呢为什么点不动呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64386577686, createdName=ms5000000616006692, createdTime=Thu Jul 14 23:59:28 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101472, encodeId=ef1b21014e262, content=BJO对临床研究要求的字数要求不超过3000字，缩减有点困难啊，超出一点点有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38f11459787, createdName=cwhmaria, createdTime=Sat Nov 19 10:45:07 CST 2022, time=2022-11-19, status=1, ipAttribution=)]

2020-08-22 1259c4d1m39暂无昵称

WB实验只重复了3次，然后做了转录组学，一共3组，每组n＝3，其他的实验倒是都n＞5，请问这种n<5的情况还能解释抢救一下吗😌😌，要是解释又该咋解释呢？跪求过来人指点迷津！！！

245 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=812012, encodeId=f4f6812012b1, content=WB实验只重复了3次，然后做了转录组学，一共3组，每组n＝3，其他的实验倒是都n＞5，请问这种n<5的情况还能解释抢救一下吗😌😌，要是解释又该咋解释呢？跪求过来人指点迷津！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa7c2578479, createdName=1259c4d1m39暂无昵称, createdTime=Sat Aug 22 11:39:16 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890345, encodeId=1760890345d5, content=投稿历程： 9-26日：投稿 27日：退回修改 27日：再投 27日：Awaiting Admin Processing 29日：Awaiting SE Assignment 10-1日：Under Review 10-6日（周二）：Under Review 太快Under Review有可能是编辑内审，周一没有拒掉，看来是送外审了！希望能有个好消息。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82d75423544, createdName=胡墨乙, createdTime=Tue Oct 06 09:53:37 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225505, encodeId=fea81225505f2, content=投稿3天就显示：ADM: Office, Editorial Under Review，到现在已经10天还是这个状态，请问是送外审了还是还在编辑手里评估？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Thu Jun 09 20:43:19 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099754, encodeId=ac872099e5448, content=一审快5个月了，还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Thu Nov 10 22:45:24 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153667, encodeId=8f59215366ec8, content=很快显示Under review是还没送审么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=649b5469159, createdName=ms6000000380819267, createdTime=Sun Aug 20 00:27:15 CST 2023, time=2023-08-20, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2178598, encodeId=eff821e8598a9, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药学 经验分享：最新的中科院分区显示为2区非top，一个老牌药学期刊现在日落西山，真是令人大跌眼镜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1a4b2101714, createdName=有时候有石猴, createdTime=Mon Jan 01 15:26:49 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130419, encodeId=354f2130419da, content=状态是Office, Editorial，under review是编辑在看，还没送审吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da598638523, createdName=ms7000000124702508, createdTime=Sat May 06 11:02:30 CST 2023, time=2023-05-06, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=567095, encodeId=4a8c56e09554, content=投稿命中率:25.0 经验分享：2019年1月23 日投稿，十天之后要求提供由于投稿figure 中的 western-blot 原始图，当日提交原始图，原始图不用做任何说明，我们是将fugure图放上然后原始图放旁边，有时候一张膜上跑其他实验也没关系，只要是原始图就成，一周之后拒稿，理由是实验需要重复五次以上，我们只做三次~ 拒稿还是很快的~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbxIPfCRw9M3DTmzkUQmibZbat4YUHNQoajZUkJX9iaYPyTKicX9S8yeqW1hG0oiaj8rF3j0WalWoicmA/132, createdBy=1e302549420, createdName=young926, createdTime=Fri Feb 22 01:11:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232551, encodeId=02ea123255182, content=请问投稿时作者和机构那一步是添加什么邮箱呢为什么点不动呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64386577686, createdName=ms5000000616006692, createdTime=Thu Jul 14 23:59:28 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101472, encodeId=ef1b21014e262, content=BJO对临床研究要求的字数要求不超过3000字，缩减有点困难啊，超出一点点有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38f11459787, createdName=cwhmaria, createdTime=Sat Nov 19 10:45:07 CST 2022, time=2022-11-19, status=1, ipAttribution=)]

2020-10-06 胡墨乙

投稿历程： 9-26日：投稿 27日：退回修改 27日：再投 27日：Awaiting Admin Processing 29日：Awaiting SE Assignment 10-1日：Under Review 10-6日（周二）：Under Review 太快Under Review有可能是编辑内审，周一没有拒掉，看来是送外审了！希望能有个好消息。

268 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=812012, encodeId=f4f6812012b1, content=WB实验只重复了3次，然后做了转录组学，一共3组，每组n＝3，其他的实验倒是都n＞5，请问这种n<5的情况还能解释抢救一下吗😌😌，要是解释又该咋解释呢？跪求过来人指点迷津！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa7c2578479, createdName=1259c4d1m39暂无昵称, createdTime=Sat Aug 22 11:39:16 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890345, encodeId=1760890345d5, content=投稿历程： 9-26日：投稿 27日：退回修改 27日：再投 27日：Awaiting Admin Processing 29日：Awaiting SE Assignment 10-1日：Under Review 10-6日（周二）：Under Review 太快Under Review有可能是编辑内审，周一没有拒掉，看来是送外审了！希望能有个好消息。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82d75423544, createdName=胡墨乙, createdTime=Tue Oct 06 09:53:37 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225505, encodeId=fea81225505f2, content=投稿3天就显示：ADM: Office, Editorial Under Review，到现在已经10天还是这个状态，请问是送外审了还是还在编辑手里评估？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Thu Jun 09 20:43:19 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099754, encodeId=ac872099e5448, content=一审快5个月了，还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Thu Nov 10 22:45:24 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153667, encodeId=8f59215366ec8, content=很快显示Under review是还没送审么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=649b5469159, createdName=ms6000000380819267, createdTime=Sun Aug 20 00:27:15 CST 2023, time=2023-08-20, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2178598, encodeId=eff821e8598a9, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药学 经验分享：最新的中科院分区显示为2区非top，一个老牌药学期刊现在日落西山，真是令人大跌眼镜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1a4b2101714, createdName=有时候有石猴, createdTime=Mon Jan 01 15:26:49 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130419, encodeId=354f2130419da, content=状态是Office, Editorial，under review是编辑在看，还没送审吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da598638523, createdName=ms7000000124702508, createdTime=Sat May 06 11:02:30 CST 2023, time=2023-05-06, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=567095, encodeId=4a8c56e09554, content=投稿命中率:25.0 经验分享：2019年1月23 日投稿，十天之后要求提供由于投稿figure 中的 western-blot 原始图，当日提交原始图，原始图不用做任何说明，我们是将fugure图放上然后原始图放旁边，有时候一张膜上跑其他实验也没关系，只要是原始图就成，一周之后拒稿，理由是实验需要重复五次以上，我们只做三次~ 拒稿还是很快的~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbxIPfCRw9M3DTmzkUQmibZbat4YUHNQoajZUkJX9iaYPyTKicX9S8yeqW1hG0oiaj8rF3j0WalWoicmA/132, createdBy=1e302549420, createdName=young926, createdTime=Fri Feb 22 01:11:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232551, encodeId=02ea123255182, content=请问投稿时作者和机构那一步是添加什么邮箱呢为什么点不动呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64386577686, createdName=ms5000000616006692, createdTime=Thu Jul 14 23:59:28 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101472, encodeId=ef1b21014e262, content=BJO对临床研究要求的字数要求不超过3000字，缩减有点困难啊，超出一点点有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38f11459787, createdName=cwhmaria, createdTime=Sat Nov 19 10:45:07 CST 2022, time=2022-11-19, status=1, ipAttribution=)]

2022-06-09 JayNi

投稿3天就显示：ADM: Office, Editorial Under Review，到现在已经10天还是这个状态，请问是送外审了还是还在编辑手里评估？

158 38

展开38条回复

[GetPortalCommentsPageByObjectIdResponse(id=812012, encodeId=f4f6812012b1, content=WB实验只重复了3次，然后做了转录组学，一共3组，每组n＝3，其他的实验倒是都n＞5，请问这种n<5的情况还能解释抢救一下吗😌😌，要是解释又该咋解释呢？跪求过来人指点迷津！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa7c2578479, createdName=1259c4d1m39暂无昵称, createdTime=Sat Aug 22 11:39:16 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890345, encodeId=1760890345d5, content=投稿历程： 9-26日：投稿 27日：退回修改 27日：再投 27日：Awaiting Admin Processing 29日：Awaiting SE Assignment 10-1日：Under Review 10-6日（周二）：Under Review 太快Under Review有可能是编辑内审，周一没有拒掉，看来是送外审了！希望能有个好消息。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82d75423544, createdName=胡墨乙, createdTime=Tue Oct 06 09:53:37 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225505, encodeId=fea81225505f2, content=投稿3天就显示：ADM: Office, Editorial Under Review，到现在已经10天还是这个状态，请问是送外审了还是还在编辑手里评估？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Thu Jun 09 20:43:19 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099754, encodeId=ac872099e5448, content=一审快5个月了，还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Thu Nov 10 22:45:24 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153667, encodeId=8f59215366ec8, content=很快显示Under review是还没送审么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=649b5469159, createdName=ms6000000380819267, createdTime=Sun Aug 20 00:27:15 CST 2023, time=2023-08-20, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2178598, encodeId=eff821e8598a9, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药学 经验分享：最新的中科院分区显示为2区非top，一个老牌药学期刊现在日落西山，真是令人大跌眼镜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1a4b2101714, createdName=有时候有石猴, createdTime=Mon Jan 01 15:26:49 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130419, encodeId=354f2130419da, content=状态是Office, Editorial，under review是编辑在看，还没送审吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da598638523, createdName=ms7000000124702508, createdTime=Sat May 06 11:02:30 CST 2023, time=2023-05-06, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=567095, encodeId=4a8c56e09554, content=投稿命中率:25.0 经验分享：2019年1月23 日投稿，十天之后要求提供由于投稿figure 中的 western-blot 原始图，当日提交原始图，原始图不用做任何说明，我们是将fugure图放上然后原始图放旁边，有时候一张膜上跑其他实验也没关系，只要是原始图就成，一周之后拒稿，理由是实验需要重复五次以上，我们只做三次~ 拒稿还是很快的~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbxIPfCRw9M3DTmzkUQmibZbat4YUHNQoajZUkJX9iaYPyTKicX9S8yeqW1hG0oiaj8rF3j0WalWoicmA/132, createdBy=1e302549420, createdName=young926, createdTime=Fri Feb 22 01:11:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232551, encodeId=02ea123255182, content=请问投稿时作者和机构那一步是添加什么邮箱呢为什么点不动呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64386577686, createdName=ms5000000616006692, createdTime=Thu Jul 14 23:59:28 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101472, encodeId=ef1b21014e262, content=BJO对临床研究要求的字数要求不超过3000字，缩减有点困难啊，超出一点点有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38f11459787, createdName=cwhmaria, createdTime=Sat Nov 19 10:45:07 CST 2022, time=2022-11-19, status=1, ipAttribution=)]

2022-11-10 wy-liang

一审快5个月了，还没消息

107 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=812012, encodeId=f4f6812012b1, content=WB实验只重复了3次，然后做了转录组学，一共3组，每组n＝3，其他的实验倒是都n＞5，请问这种n<5的情况还能解释抢救一下吗😌😌，要是解释又该咋解释呢？跪求过来人指点迷津！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa7c2578479, createdName=1259c4d1m39暂无昵称, createdTime=Sat Aug 22 11:39:16 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890345, encodeId=1760890345d5, content=投稿历程： 9-26日：投稿 27日：退回修改 27日：再投 27日：Awaiting Admin Processing 29日：Awaiting SE Assignment 10-1日：Under Review 10-6日（周二）：Under Review 太快Under Review有可能是编辑内审，周一没有拒掉，看来是送外审了！希望能有个好消息。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82d75423544, createdName=胡墨乙, createdTime=Tue Oct 06 09:53:37 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225505, encodeId=fea81225505f2, content=投稿3天就显示：ADM: Office, Editorial Under Review，到现在已经10天还是这个状态，请问是送外审了还是还在编辑手里评估？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Thu Jun 09 20:43:19 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099754, encodeId=ac872099e5448, content=一审快5个月了，还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Thu Nov 10 22:45:24 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153667, encodeId=8f59215366ec8, content=很快显示Under review是还没送审么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=649b5469159, createdName=ms6000000380819267, createdTime=Sun Aug 20 00:27:15 CST 2023, time=2023-08-20, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2178598, encodeId=eff821e8598a9, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药学 经验分享：最新的中科院分区显示为2区非top，一个老牌药学期刊现在日落西山，真是令人大跌眼镜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1a4b2101714, createdName=有时候有石猴, createdTime=Mon Jan 01 15:26:49 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130419, encodeId=354f2130419da, content=状态是Office, Editorial，under review是编辑在看，还没送审吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da598638523, createdName=ms7000000124702508, createdTime=Sat May 06 11:02:30 CST 2023, time=2023-05-06, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=567095, encodeId=4a8c56e09554, content=投稿命中率:25.0 经验分享：2019年1月23 日投稿，十天之后要求提供由于投稿figure 中的 western-blot 原始图，当日提交原始图，原始图不用做任何说明，我们是将fugure图放上然后原始图放旁边，有时候一张膜上跑其他实验也没关系，只要是原始图就成，一周之后拒稿，理由是实验需要重复五次以上，我们只做三次~ 拒稿还是很快的~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbxIPfCRw9M3DTmzkUQmibZbat4YUHNQoajZUkJX9iaYPyTKicX9S8yeqW1hG0oiaj8rF3j0WalWoicmA/132, createdBy=1e302549420, createdName=young926, createdTime=Fri Feb 22 01:11:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232551, encodeId=02ea123255182, content=请问投稿时作者和机构那一步是添加什么邮箱呢为什么点不动呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64386577686, createdName=ms5000000616006692, createdTime=Thu Jul 14 23:59:28 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101472, encodeId=ef1b21014e262, content=BJO对临床研究要求的字数要求不超过3000字，缩减有点困难啊，超出一点点有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38f11459787, createdName=cwhmaria, createdTime=Sat Nov 19 10:45:07 CST 2022, time=2022-11-19, status=1, ipAttribution=)]

2023-08-20 ms6000000380819267 来自密歇根

很快显示Under review是还没送审么

105 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=812012, encodeId=f4f6812012b1, content=WB实验只重复了3次，然后做了转录组学，一共3组，每组n＝3，其他的实验倒是都n＞5，请问这种n<5的情况还能解释抢救一下吗😌😌，要是解释又该咋解释呢？跪求过来人指点迷津！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa7c2578479, createdName=1259c4d1m39暂无昵称, createdTime=Sat Aug 22 11:39:16 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890345, encodeId=1760890345d5, content=投稿历程： 9-26日：投稿 27日：退回修改 27日：再投 27日：Awaiting Admin Processing 29日：Awaiting SE Assignment 10-1日：Under Review 10-6日（周二）：Under Review 太快Under Review有可能是编辑内审，周一没有拒掉，看来是送外审了！希望能有个好消息。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82d75423544, createdName=胡墨乙, createdTime=Tue Oct 06 09:53:37 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225505, encodeId=fea81225505f2, content=投稿3天就显示：ADM: Office, Editorial Under Review，到现在已经10天还是这个状态，请问是送外审了还是还在编辑手里评估？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Thu Jun 09 20:43:19 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099754, encodeId=ac872099e5448, content=一审快5个月了，还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Thu Nov 10 22:45:24 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153667, encodeId=8f59215366ec8, content=很快显示Under review是还没送审么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=649b5469159, createdName=ms6000000380819267, createdTime=Sun Aug 20 00:27:15 CST 2023, time=2023-08-20, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2178598, encodeId=eff821e8598a9, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药学 经验分享：最新的中科院分区显示为2区非top，一个老牌药学期刊现在日落西山，真是令人大跌眼镜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1a4b2101714, createdName=有时候有石猴, createdTime=Mon Jan 01 15:26:49 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130419, encodeId=354f2130419da, content=状态是Office, Editorial，under review是编辑在看，还没送审吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da598638523, createdName=ms7000000124702508, createdTime=Sat May 06 11:02:30 CST 2023, time=2023-05-06, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=567095, encodeId=4a8c56e09554, content=投稿命中率:25.0 经验分享：2019年1月23 日投稿，十天之后要求提供由于投稿figure 中的 western-blot 原始图，当日提交原始图，原始图不用做任何说明，我们是将fugure图放上然后原始图放旁边，有时候一张膜上跑其他实验也没关系，只要是原始图就成，一周之后拒稿，理由是实验需要重复五次以上，我们只做三次~ 拒稿还是很快的~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbxIPfCRw9M3DTmzkUQmibZbat4YUHNQoajZUkJX9iaYPyTKicX9S8yeqW1hG0oiaj8rF3j0WalWoicmA/132, createdBy=1e302549420, createdName=young926, createdTime=Fri Feb 22 01:11:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232551, encodeId=02ea123255182, content=请问投稿时作者和机构那一步是添加什么邮箱呢为什么点不动呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64386577686, createdName=ms5000000616006692, createdTime=Thu Jul 14 23:59:28 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101472, encodeId=ef1b21014e262, content=BJO对临床研究要求的字数要求不超过3000字，缩减有点困难啊，超出一点点有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38f11459787, createdName=cwhmaria, createdTime=Sat Nov 19 10:45:07 CST 2022, time=2022-11-19, status=1, ipAttribution=)]

2024-01-01 有时候有石猴来自广东省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：药学
经验分享：最新的中科院分区显示为2区非top，一个老牌药学期刊现在日落西山，真是令人大跌眼镜！

80 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=812012, encodeId=f4f6812012b1, content=WB实验只重复了3次，然后做了转录组学，一共3组，每组n＝3，其他的实验倒是都n＞5，请问这种n<5的情况还能解释抢救一下吗😌😌，要是解释又该咋解释呢？跪求过来人指点迷津！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa7c2578479, createdName=1259c4d1m39暂无昵称, createdTime=Sat Aug 22 11:39:16 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890345, encodeId=1760890345d5, content=投稿历程： 9-26日：投稿 27日：退回修改 27日：再投 27日：Awaiting Admin Processing 29日：Awaiting SE Assignment 10-1日：Under Review 10-6日（周二）：Under Review 太快Under Review有可能是编辑内审，周一没有拒掉，看来是送外审了！希望能有个好消息。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82d75423544, createdName=胡墨乙, createdTime=Tue Oct 06 09:53:37 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225505, encodeId=fea81225505f2, content=投稿3天就显示：ADM: Office, Editorial Under Review，到现在已经10天还是这个状态，请问是送外审了还是还在编辑手里评估？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Thu Jun 09 20:43:19 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099754, encodeId=ac872099e5448, content=一审快5个月了，还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Thu Nov 10 22:45:24 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153667, encodeId=8f59215366ec8, content=很快显示Under review是还没送审么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=649b5469159, createdName=ms6000000380819267, createdTime=Sun Aug 20 00:27:15 CST 2023, time=2023-08-20, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2178598, encodeId=eff821e8598a9, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药学 经验分享：最新的中科院分区显示为2区非top，一个老牌药学期刊现在日落西山，真是令人大跌眼镜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1a4b2101714, createdName=有时候有石猴, createdTime=Mon Jan 01 15:26:49 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130419, encodeId=354f2130419da, content=状态是Office, Editorial，under review是编辑在看，还没送审吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da598638523, createdName=ms7000000124702508, createdTime=Sat May 06 11:02:30 CST 2023, time=2023-05-06, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=567095, encodeId=4a8c56e09554, content=投稿命中率:25.0 经验分享：2019年1月23 日投稿，十天之后要求提供由于投稿figure 中的 western-blot 原始图，当日提交原始图，原始图不用做任何说明，我们是将fugure图放上然后原始图放旁边，有时候一张膜上跑其他实验也没关系，只要是原始图就成，一周之后拒稿，理由是实验需要重复五次以上，我们只做三次~ 拒稿还是很快的~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbxIPfCRw9M3DTmzkUQmibZbat4YUHNQoajZUkJX9iaYPyTKicX9S8yeqW1hG0oiaj8rF3j0WalWoicmA/132, createdBy=1e302549420, createdName=young926, createdTime=Fri Feb 22 01:11:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232551, encodeId=02ea123255182, content=请问投稿时作者和机构那一步是添加什么邮箱呢为什么点不动呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64386577686, createdName=ms5000000616006692, createdTime=Thu Jul 14 23:59:28 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101472, encodeId=ef1b21014e262, content=BJO对临床研究要求的字数要求不超过3000字，缩减有点困难啊，超出一点点有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38f11459787, createdName=cwhmaria, createdTime=Sat Nov 19 10:45:07 CST 2022, time=2022-11-19, status=1, ipAttribution=)]

2023-05-06 ms7000000124702508 来自安徽省

状态是Office, Editorial，under review是编辑在看，还没送审吧？

129 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=812012, encodeId=f4f6812012b1, content=WB实验只重复了3次，然后做了转录组学，一共3组，每组n＝3，其他的实验倒是都n＞5，请问这种n<5的情况还能解释抢救一下吗😌😌，要是解释又该咋解释呢？跪求过来人指点迷津！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa7c2578479, createdName=1259c4d1m39暂无昵称, createdTime=Sat Aug 22 11:39:16 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890345, encodeId=1760890345d5, content=投稿历程： 9-26日：投稿 27日：退回修改 27日：再投 27日：Awaiting Admin Processing 29日：Awaiting SE Assignment 10-1日：Under Review 10-6日（周二）：Under Review 太快Under Review有可能是编辑内审，周一没有拒掉，看来是送外审了！希望能有个好消息。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82d75423544, createdName=胡墨乙, createdTime=Tue Oct 06 09:53:37 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225505, encodeId=fea81225505f2, content=投稿3天就显示：ADM: Office, Editorial Under Review，到现在已经10天还是这个状态，请问是送外审了还是还在编辑手里评估？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Thu Jun 09 20:43:19 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099754, encodeId=ac872099e5448, content=一审快5个月了，还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Thu Nov 10 22:45:24 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153667, encodeId=8f59215366ec8, content=很快显示Under review是还没送审么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=649b5469159, createdName=ms6000000380819267, createdTime=Sun Aug 20 00:27:15 CST 2023, time=2023-08-20, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2178598, encodeId=eff821e8598a9, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药学 经验分享：最新的中科院分区显示为2区非top，一个老牌药学期刊现在日落西山，真是令人大跌眼镜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1a4b2101714, createdName=有时候有石猴, createdTime=Mon Jan 01 15:26:49 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130419, encodeId=354f2130419da, content=状态是Office, Editorial，under review是编辑在看，还没送审吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da598638523, createdName=ms7000000124702508, createdTime=Sat May 06 11:02:30 CST 2023, time=2023-05-06, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=567095, encodeId=4a8c56e09554, content=投稿命中率:25.0 经验分享：2019年1月23 日投稿，十天之后要求提供由于投稿figure 中的 western-blot 原始图，当日提交原始图，原始图不用做任何说明，我们是将fugure图放上然后原始图放旁边，有时候一张膜上跑其他实验也没关系，只要是原始图就成，一周之后拒稿，理由是实验需要重复五次以上，我们只做三次~ 拒稿还是很快的~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbxIPfCRw9M3DTmzkUQmibZbat4YUHNQoajZUkJX9iaYPyTKicX9S8yeqW1hG0oiaj8rF3j0WalWoicmA/132, createdBy=1e302549420, createdName=young926, createdTime=Fri Feb 22 01:11:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232551, encodeId=02ea123255182, content=请问投稿时作者和机构那一步是添加什么邮箱呢为什么点不动呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64386577686, createdName=ms5000000616006692, createdTime=Thu Jul 14 23:59:28 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101472, encodeId=ef1b21014e262, content=BJO对临床研究要求的字数要求不超过3000字，缩减有点困难啊，超出一点点有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38f11459787, createdName=cwhmaria, createdTime=Sat Nov 19 10:45:07 CST 2022, time=2022-11-19, status=1, ipAttribution=)]

2019-02-22 young926

投稿命中率:25.0
经验分享：2019年1月23 日投稿，十天之后要求提供由于投稿figure 中的 western-blot 原始图，当日提交原始图，原始图不用做任何说明，我们是将fugure图放上然后原始图放旁边，有时候一张膜上跑其他实验也没关系，只要是原始图就成，一周之后拒稿，理由是实验需要重复五次以上，我们只做三次~ 拒稿还是很快的~

174 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=812012, encodeId=f4f6812012b1, content=WB实验只重复了3次，然后做了转录组学，一共3组，每组n＝3，其他的实验倒是都n＞5，请问这种n<5的情况还能解释抢救一下吗😌😌，要是解释又该咋解释呢？跪求过来人指点迷津！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa7c2578479, createdName=1259c4d1m39暂无昵称, createdTime=Sat Aug 22 11:39:16 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890345, encodeId=1760890345d5, content=投稿历程： 9-26日：投稿 27日：退回修改 27日：再投 27日：Awaiting Admin Processing 29日：Awaiting SE Assignment 10-1日：Under Review 10-6日（周二）：Under Review 太快Under Review有可能是编辑内审，周一没有拒掉，看来是送外审了！希望能有个好消息。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82d75423544, createdName=胡墨乙, createdTime=Tue Oct 06 09:53:37 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225505, encodeId=fea81225505f2, content=投稿3天就显示：ADM: Office, Editorial Under Review，到现在已经10天还是这个状态，请问是送外审了还是还在编辑手里评估？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Thu Jun 09 20:43:19 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099754, encodeId=ac872099e5448, content=一审快5个月了，还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Thu Nov 10 22:45:24 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153667, encodeId=8f59215366ec8, content=很快显示Under review是还没送审么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=649b5469159, createdName=ms6000000380819267, createdTime=Sun Aug 20 00:27:15 CST 2023, time=2023-08-20, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2178598, encodeId=eff821e8598a9, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药学 经验分享：最新的中科院分区显示为2区非top，一个老牌药学期刊现在日落西山，真是令人大跌眼镜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1a4b2101714, createdName=有时候有石猴, createdTime=Mon Jan 01 15:26:49 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130419, encodeId=354f2130419da, content=状态是Office, Editorial，under review是编辑在看，还没送审吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da598638523, createdName=ms7000000124702508, createdTime=Sat May 06 11:02:30 CST 2023, time=2023-05-06, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=567095, encodeId=4a8c56e09554, content=投稿命中率:25.0 经验分享：2019年1月23 日投稿，十天之后要求提供由于投稿figure 中的 western-blot 原始图，当日提交原始图，原始图不用做任何说明，我们是将fugure图放上然后原始图放旁边，有时候一张膜上跑其他实验也没关系，只要是原始图就成，一周之后拒稿，理由是实验需要重复五次以上，我们只做三次~ 拒稿还是很快的~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbxIPfCRw9M3DTmzkUQmibZbat4YUHNQoajZUkJX9iaYPyTKicX9S8yeqW1hG0oiaj8rF3j0WalWoicmA/132, createdBy=1e302549420, createdName=young926, createdTime=Fri Feb 22 01:11:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232551, encodeId=02ea123255182, content=请问投稿时作者和机构那一步是添加什么邮箱呢为什么点不动呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64386577686, createdName=ms5000000616006692, createdTime=Thu Jul 14 23:59:28 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101472, encodeId=ef1b21014e262, content=BJO对临床研究要求的字数要求不超过3000字，缩减有点困难啊，超出一点点有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38f11459787, createdName=cwhmaria, createdTime=Sat Nov 19 10:45:07 CST 2022, time=2022-11-19, status=1, ipAttribution=)]

2022-07-14 ms5000000616006692

请问投稿时作者和机构那一步是添加什么邮箱呢为什么点不动呀

127 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=812012, encodeId=f4f6812012b1, content=WB实验只重复了3次，然后做了转录组学，一共3组，每组n＝3，其他的实验倒是都n＞5，请问这种n<5的情况还能解释抢救一下吗😌😌，要是解释又该咋解释呢？跪求过来人指点迷津！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=245, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa7c2578479, createdName=1259c4d1m39暂无昵称, createdTime=Sat Aug 22 11:39:16 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890345, encodeId=1760890345d5, content=投稿历程： 9-26日：投稿 27日：退回修改 27日：再投 27日：Awaiting Admin Processing 29日：Awaiting SE Assignment 10-1日：Under Review 10-6日（周二）：Under Review 太快Under Review有可能是编辑内审，周一没有拒掉，看来是送外审了！希望能有个好消息。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82d75423544, createdName=胡墨乙, createdTime=Tue Oct 06 09:53:37 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1225505, encodeId=fea81225505f2, content=投稿3天就显示：ADM: Office, Editorial Under Review，到现在已经10天还是这个状态，请问是送外审了还是还在编辑手里评估？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=38, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210112/9d391e0b1cd74e869f11d621441146a1/0f85d4b8f25545bc8cd6ff7d737de80d.jpg, createdBy=8aaa108952, createdName=JayNi, createdTime=Thu Jun 09 20:43:19 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099754, encodeId=ac872099e5448, content=一审快5个月了，还没消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Thu Nov 10 22:45:24 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153667, encodeId=8f59215366ec8, content=很快显示Under review是还没送审么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=649b5469159, createdName=ms6000000380819267, createdTime=Sun Aug 20 00:27:15 CST 2023, time=2023-08-20, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2178598, encodeId=eff821e8598a9, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：药学 经验分享：最新的中科院分区显示为2区非top，一个老牌药学期刊现在日落西山，真是令人大跌眼镜！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1a4b2101714, createdName=有时候有石猴, createdTime=Mon Jan 01 15:26:49 CST 2024, time=2024-01-01, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2130419, encodeId=354f2130419da, content=状态是Office, Editorial，under review是编辑在看，还没送审吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da598638523, createdName=ms7000000124702508, createdTime=Sat May 06 11:02:30 CST 2023, time=2023-05-06, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=567095, encodeId=4a8c56e09554, content=投稿命中率:25.0 经验分享：2019年1月23 日投稿，十天之后要求提供由于投稿figure 中的 western-blot 原始图，当日提交原始图，原始图不用做任何说明，我们是将fugure图放上然后原始图放旁边，有时候一张膜上跑其他实验也没关系，只要是原始图就成，一周之后拒稿，理由是实验需要重复五次以上，我们只做三次~ 拒稿还是很快的~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKbxIPfCRw9M3DTmzkUQmibZbat4YUHNQoajZUkJX9iaYPyTKicX9S8yeqW1hG0oiaj8rF3j0WalWoicmA/132, createdBy=1e302549420, createdName=young926, createdTime=Fri Feb 22 01:11:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232551, encodeId=02ea123255182, content=请问投稿时作者和机构那一步是添加什么邮箱呢为什么点不动呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64386577686, createdName=ms5000000616006692, createdTime=Thu Jul 14 23:59:28 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101472, encodeId=ef1b21014e262, content=BJO对临床研究要求的字数要求不超过3000字，缩减有点困难啊，超出一点点有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=38f11459787, createdName=cwhmaria, createdTime=Sat Nov 19 10:45:07 CST 2022, time=2022-11-19, status=1, ipAttribution=)]

2022-11-19 cwhmaria

BJO对临床研究要求的字数要求不超过3000字，缩减有点困难啊，超出一点点有关系吗？

106 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务